Aliases & Classifications for Fecal Incontinence

MalaCards integrated aliases for Fecal Incontinence:

Name: Fecal Incontinence 37 69

External Ids:

UMLS 69 C0015732

Summaries for Fecal Incontinence

MalaCards based summary : Fecal Incontinence is related to insensitivity to pain, congenital, with anhidrosis and meningovascular neurosyphilis, and has symptoms including full incontinence of feces, symptoms and disturbance in bowel function. The drugs Glycerol and Loperamide have been mentioned in the context of this disorder. Affiliated tissues include Adipose and Adipose.

Wikipedia : 72 Fecal incontinence (FI), also known as anal incontinence, or in some forms encopresis, is a lack of... more...

Related Diseases for Fecal Incontinence

Diseases related to Fecal Incontinence via text searches within MalaCards or GeneCards Suite gene sharing:

(show all 50)
# Related Disease Score Top Affiliating Genes
1 insensitivity to pain, congenital, with anhidrosis 11.0
2 meningovascular neurosyphilis 11.0
3 lymphocytic colitis 11.0
4 steatorrhea 11.0
5 pudendal neuralgia 11.0
6 constipation 10.6
7 pelvic organ prolapse 10.4
8 aging 10.3
9 body mass index quantitative trait locus 11 10.2
10 body mass index quantitative trait locus 9 10.2
11 body mass index quantitative trait locus 8 10.2
12 body mass index quantitative trait locus 4 10.2
13 body mass index quantitative trait locus 10 10.2
14 body mass index quantitative trait locus 7 10.2
15 body mass index quantitative trait locus 12 10.2
16 body mass index quantitative trait locus 14 10.2
17 body mass index quantitative trait locus 18 10.2
18 vaginitis 10.2
19 anus, imperforate 10.2
20 prostate cancer 10.2
21 neural tube defects 10.2
22 prostatitis 10.2
23 dermatitis 10.2
24 hirschsprung disease 1 10.1
25 inflammatory bowel disease 10.1
26 neuropathy 10.1
27 irritable bowel syndrome 10.0
28 anorectal anomalies 10.0
29 scleroderma, familial progressive 10.0
30 crohn's disease 10.0
31 dementia 10.0
32 anus disease 10.0
33 colorectal cancer 9.8
34 attention deficit-hyperactivity disorder 9.8
35 osteoporosis 9.8
36 celiac disease 1 9.8
37 paine syndrome 9.8
38 exstrophy of bladder 9.8
39 bone mineral density quantitative trait locus 8 9.8
40 bone mineral density quantitative trait locus 15 9.8
41 episodic pain syndrome, familial, 1 9.8
42 morbid obesity 9.8
43 myelomeningocele 9.8
44 autonomic neuropathy 9.8
45 gastroparesis 9.8
46 diarrhea 9.8
47 complex regional pain syndrome 9.8
48 cerebritis 9.8
49 kidney disease 9.8
50 neuronitis 9.8

Comorbidity relations with Fecal Incontinence via Phenotypic Disease Network (PDN):


Acute Cystitis Alzheimer Disease
Decubitus Ulcer Deficiency Anemia
Heart Disease Hypertension, Essential
Parkinson Disease, Late-Onset Pelvic Organ Prolapse
Protein-Energy Malnutrition Schizophreniform Disorder

Graphical network of the top 20 diseases related to Fecal Incontinence:



Diseases related to Fecal Incontinence

Symptoms & Phenotypes for Fecal Incontinence

UMLS symptoms related to Fecal Incontinence:


full incontinence of feces, symptoms, disturbance in bowel function, colonic inertia, hot flushes, gastrointestinal gas, bowel urgency, rectal tenesmus, other symptoms involving digestive system, symptoms involving digestive system, vertigo, syncope, signs and symptoms, digestive, signs and symptoms, seizures, nausea and vomiting, icterus, heartburn, headache, flatulence, eructation, and gas pain, fever, edema, dyspnea, dyspepsia, diarrhea, cyanosis, constipation, cachexia, abdominal pain

Drugs & Therapeutics for Fecal Incontinence

Drugs for Fecal Incontinence (from DrugBank, HMDB, Dgidb, PharmGKB, IUPHAR, NovoSeek, BitterDB):

(show top 50) (show all 202)
# Name Status Phase Clinical Trials Cas Number PubChem Id
1
Glycerol Approved, Investigational Phase 4 56-81-5 753
2
Loperamide Approved Phase 4,Phase 2,Phase 3 53179-11-6 3955
3
Lubiprostone Approved, Investigational Phase 4 136790-76-6 656719
4 Gastrointestinal Agents Phase 4,Phase 2,Phase 3
5 Pharmaceutical Solutions Phase 4,Phase 2,Phase 3,Phase 1
6 Antidiarrheals Phase 4,Phase 2,Phase 3
7 Calcium polycarbophil Phase 4,Phase 2,Phase 3
8 Calcium, Dietary Phase 4,Phase 2,Phase 3
9 Cathartics Phase 4,Phase 2,Phase 3
10 Laxatives Phase 4,Phase 2,Phase 3
11 Protective Agents Phase 4,Phase 3,Phase 1,Phase 2
12 Acidophilus Nutraceutical Phase 4,Phase 2
13 Cola Nutraceutical Phase 4
14 Psyllium Nutraceutical Phase 4,Phase 2,Phase 3
15
Menthol Approved Phase 3,Phase 1 2216-51-5 16666
16
Metronidazole Approved Phase 3 443-48-1 4173
17
Lactulose Approved Phase 3 4618-18-2 11333
18
Carboplatin Approved Phase 3 41575-94-4 10339178 38904 498142
19
Gemcitabine Approved Phase 3 95058-81-4 60750
20
Hydroxocobalamin Approved Phase 3 13422-51-0 5460373 44475014 11953898
21
Pemetrexed Approved, Investigational Phase 3 150399-23-8, 137281-23-3 60843 446556
22
Clonidine Approved Phase 3,Phase 2 4205-90-7 2803
23
Bisacodyl Approved Phase 3,Phase 2 603-50-9
24
Ephedrine Approved Phase 3,Phase 1,Phase 2 299-42-3 9294
25
Oxymetazoline Approved, Investigational Phase 3,Phase 1,Phase 2 1491-59-4 4636
26
Phenylephrine Approved Phase 3,Phase 1,Phase 2 59-42-7 6041
27
Pseudoephedrine Approved Phase 3,Phase 1,Phase 2 90-82-4 7028
28
Acetylcholine Approved Phase 3,Phase 2 51-84-3 187
29
Cyproterone Acetate Approved, Investigational Phase 3 427-51-0
30
Estradiol Approved, Investigational, Vet_approved Phase 3 50-28-2 5757
31
Cyanocobalamin Approved, Nutraceutical Phase 3 68-19-9 44176380
32
Folic Acid Approved, Nutraceutical, Vet_approved Phase 3 59-30-3 6037
33
leucovorin Approved, Nutraceutical Phase 3 58-05-9 143 6006
34
Docetaxel Approved May 1996, Investigational Phase 3 114977-28-5 148124 9877265
35 Anti-Infective Agents Phase 3
36 Coagulants Phase 3,Phase 1
37 Fibrin Tissue Adhesive Phase 3,Phase 1
38 Hemostatics Phase 3,Phase 1
39 abobotulinumtoxinA Phase 3,Phase 2
40 Botulinum Toxins, Type A Phase 3,Phase 2
41 onabotulinumtoxinA Phase 3,Phase 2
42 Anesthetics Phase 3,Phase 1,Phase 2
43 Antiparasitic Agents Phase 3
44 Antiprotozoal Agents Phase 3
45 Antimitotic Agents Phase 3
46 Folic Acid Antagonists Phase 3
47 Nucleic Acid Synthesis Inhibitors Phase 3
48 Vitamin B 12 Phase 3
49 Vitamin B Complex Phase 3
50 Vitamins Phase 3

Interventional clinical trials:

(show top 50) (show all 293)

# Name Status NCT ID Phase Drugs
1 Lactobacillus Reuteri in Children With Constipation Unknown status NCT01388712 Phase 4
2 HAL-RAR Versus Hemorrhoidectomy in the Treatment of Grade III-IV Hemorrhoids. Prospective, Randomized Trial Unknown status NCT02216305 Phase 4
3 Treatment of Fecal Incontinence and Constipation in Patients With Spinal Cord Injury Completed NCT00286520 Phase 4
4 Sacral Nerve Stimulation for Anal Incontinence and Bowel Control Completed NCT00200005 Phase 4
5 Polyacrylamide Hydrogel Injection Treatment for Anal Incontinence Completed NCT02550899 Phase 4
6 A Modified Surgical Approach to Women With Obstetric Anal Sphincter Tears Completed NCT01021722 Phase 4
7 Short Protocol Barostat for Assessment of Anorectal Function Versus Standard Protocol Barostat in Healthy Volunteers Completed NCT01456442 Phase 4
8 Psyllium Fiber Versus Placebo in Early Treatment After STARR for Obstructed Defecation: a Double-blind RCT Completed NCT02136693 Phase 4 Psyllium fiber;Placebo
9 A Study to Compare the Effect of Transipeg 2.95 g or Forlax Junior 4 g in Children With Constipation Completed NCT01810653 Phase 4 Macrogol (Transipeg, BAY81-8430);Macrogol (Forlax)
10 Safety and Efficacy of Lubiprostone in Pediatric Patients With Constipation Completed NCT00452335 Phase 4 Lubiprostone;Lubiprostone;Lubiprostone
11 A Within Subjects Comparison of Two Antegrade Flushing Regimens in Children Recruiting NCT02435069 Phase 4 NS and USP Glycerin - Dose Response;NS and USP Glycerin - Effectiveness
12 Clinical Efficacy of Changing the InterStim® Parameters in Patients With Interstitial Cystitis/Painful Bladder Syndrome Recruiting NCT01312259 Phase 4
13 3030-401-002 ELX BAM Study Not yet recruiting NCT03441581 Phase 4 Eluxadoline
14 Comparison of Esophageal and Anorectal Manometry Catheters Terminated NCT00204763 Phase 4
15 Imodium Syrup Versus Imodium Tablets for Faecal Incontinence Withdrawn NCT00933465 Phase 4 Imodium (Loperamide Hydrochloride) syrup;Imodium (Loperamide hydrochloride) tablets
16 Therapeutic Management of Complex Anal Fistulas by Installing a Closure Clip: Multicentre Randomized Controlled Trial Unknown status NCT02336867 Phase 2, Phase 3
17 Ligation of Intersphincteric Fistula Tract (LIFT) Versus LIFT-plug Procedure for Anal Fistula Repair Unknown status NCT01478139 Phase 3
18 Feasibility Study to Assess the Early Use of Porcine Cross-linked Collagen Paste in Cryptoglandular Anorectal Fistulas Unknown status NCT02686580 Phase 3
19 Efficacy and Mechanisms of Pharmacologic Treatment of Fecal Incontinence Completed NCT00727649 Phase 2, Phase 3 Psyllium powder;Loperamide
20 Percutaneous Tibial Nerve Stimulation in the Treatment of Fecal Incontinence Completed NCT00974909 Phase 3
21 UK Trial of Percutaneous Tibial Nerve Stimulation in Patients With Faecal Incontinence Completed NCT02349334 Phase 3
22 Autologous Myoblast Intrasphincteric Injection for Fecal Incontinence Completed NCT01523522 Phase 2, Phase 3
23 Controlling Anal Incontinence by Performing Anal Exercises With Biofeedback or Loperamide (CAPABLe) Completed NCT02008565 Phase 3 Loperamide;Placebo
24 Triple Target Treatment (3T) Which Combines Stimulation With Amplitude Modulated Middle Frequency (AM-MF), Electromyography (EMG)-Triggered Stimulation and EMG-Biofeedback Compared With EMG-Biofeedback in Anal Incontinence Completed NCT00525291 Phase 3
25 Behavioral Therapy Of Obstetric Sphincter Tears Completed NCT01166399 Phase 3
26 Does the Negativation of the Glucose Hydrogen Breath Test Come Along With a Reduction of the Symptoms of Gaz Incontinence ? Completed NCT01275560 Phase 3 Metronidazole;CArbosylane
27 To Determine the Effect of Forlax® Treatment in Children With Chronic Constipation Who May Also Suffer From Soiling/ Faecal Incontinence. Completed NCT00255372 Phase 3 PEG 4000 (Forlax®);Lactulose active and Lactulose placebo
28 Prenatal Pelvic Floor Prevention (3PN) Completed NCT00551551 Phase 3
29 Trial Involving Subjects Over 70 Years of Age With Non Small-cell Lung Cancer of Stage IV and Comparing a "Classical" Strategy of Treatment Allocation, With an"Optimized" Strategy Allocating the Same Treatments Completed NCT01257139 Phase 3
30 Efficacy and Safety of Adipose Stem Cells to Treat Complex Perianal Fistulas Not Associated to Crohn´s Disease Completed NCT00475410 Phase 3 ASCs (Cx401, company code);Fibrin adhesive
31 Prucalopride in Pediatric Subjects With Functional Constipation Completed NCT01330381 Phase 3 prucalopride;Placebo;PEG 4000
32 Pelvic Floor Muscle Training and Biofeedback or Standard Therapy in Men Who Have Undergone Radical Prostatectomy or Transurethral Resection of the Prostate Completed NCT00632138 Phase 3
33 Study to Examine the Efficacy and Safety of Movicol in the Treatment of Chronic Constipation in Children Completed NCT00403819 Phase 3 Polyethylene glycol 3350 Na bicarbonate NaCl KCl (Movicol)
34 An Open Single Centre Study To Assess Treatment of Chronic Constipation in Children Completed NCT00403897 Phase 3 Polyethylene glycol 3350 Na bicarbonate NaCl KCl
35 Effect and Tolerance of Botulinum A Toxin Rectal Injections on Fecal Incontinence Recruiting NCT02414425 Phase 3 Botulinum toxin A or physiologic serum injection
36 A Study of Colesevelam in Fecal Incontinence Recruiting NCT02628626 Phase 3 Colesevelam;Clonidine
37 MEdical Versus SUrgical Treatments of Rectal Endometriosis Recruiting NCT01973816 Phase 3 Triptoreline 11.25 i.v.; Estradiol 0.5% percutaneous gel;;Cyproterone acetate 50 mg; estradiol 0.5% percutaneous;Estradiol 0.5% percutaneous gel; Cyproterone acetate 50 mg oral
38 Encopresis & MIE (DoD #2) Recruiting NCT03197922 Phase 3
39 Bulking Agent Versus Electrostimulation Therapy in Anal Incontinence Not yet recruiting NCT03052946 Phase 2, Phase 3
40 Gore-BioA Fistula Plug to Treat Transsphincteric Fistulas Terminated NCT01584752 Phase 3
41 Sacral Neuromodulation (SNM) With InterStimTM for Bowel Dysfunction Following Surgery for Rectal Cancers With Sphincter Preservation Terminated NCT02163187 Phase 2, Phase 3
42 Seton or Glue for Trans-sphincteric Anal Fistulas Terminated NCT00929630 Phase 3
43 Comparison of PTNS and Biofeedback for Fecal Incontinence Withdrawn NCT01882101 Phase 3
44 A Study to Evaluate Topical Phenylephrine Gel in the Management of Faecal Incontinence Withdrawn NCT00420797 Phase 3 10% Phenylephrine hydrochloride gel
45 Pilot Study of NASHA/Dx Gel for Fecal Incontinence Unknown status NCT00971269 Phase 1, Phase 2
46 Stem Cells Therapy for Fecal Incontinence in Children After Posterior Sagittal Ano-rectoplasty Unknown status NCT02161003 Phase 1, Phase 2
47 Percutaneous Tibial Nerve Stimulation in the Treatment of Anterior Resection Syndrome After Rectal Cancer Surgery Unknown status NCT02177084 Phase 2
48 Percutaneous Tibial Nerve Stimulation for the Treatment of Fecal Incontinence Completed NCT00977652 Phase 2
49 A Placebo-Controlled Study of Clonidine for Fecal Incontinence. Completed NCT00884832 Phase 2 Clonidine;Placebo
50 Evaluation of Outcomes of Restoring Pelvic Floor Support With TOPAS in Women With Moderate Fecal Incontinence Symptoms Completed NCT00565136 Phase 1, Phase 2

Search NIH Clinical Center for Fecal Incontinence

Cell-based therapeutics:


LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database
Read about Fecal Incontinence cell therapies at LifeMap Discovery.

Genetic Tests for Fecal Incontinence

Anatomical Context for Fecal Incontinence

MalaCards organs/tissues related to Fecal Incontinence:

38
Colon, Spinal Cord, Testes, Prostate, Bone, Lung, Bone Marrow
LifeMap Discovery
Data from LifeMap, the Embryonic Development and Stem Cells Database

Cells/anatomical compartments in embryo or adult related to Fecal Incontinence:
# Tissue Anatomical CompartmentCell Relevance
1 Adipose Subcutaneous White Adipose Mesenchymal Stem Cells Potential therapeutic candidate
2 Adipose Subcutaneous White Adipose Stromal Cells Potential therapeutic candidate

Publications for Fecal Incontinence

Articles related to Fecal Incontinence:

(show top 50) (show all 638)
# Title Authors Year
1
Effectiveness of sacral nerve stimulation in fecal incontinence after multimodal oncologic treatment for pelvic malignancies: a multicenter study with 2-year follow-up. ( 29313165 )
2018
2
Screening for Geriatric Syndromes: Falls, Urinary/Fecal Incontinence, and Osteoporosis. ( 29129217 )
2018
3
Prevalence of and Factors Associated with Fecal Incontinence-Results From a Population-based Survey. ( 29408460 )
2018
4
Pudendal nerve terminal motor latency testing does not provide useful information in guiding therapy for fecal incontinence. ( 29330765 )
2018
5
Fecal incontinence knowledge, attitudes, and help-seeking behaviors among community-dwelling adults in Korea. ( 29331051 )
2018
6
The diagnostic value of the functional lumen imaging probe versus high-resolution anorectal manometry in patients with fecal incontinence. ( 29345097 )
2018
7
Independent risk factors for the development of incontinence-associated dermatitis (category 2) in critically ill patients with fecal incontinence: A cross-sectional observational study in 48 ICU units. ( 29428583 )
2018
8
Trends in Surgeon-Level Utilization of Sacral Nerve Stimulator Implantation for Fecal Incontinence in New York State. ( 29215481 )
2018
9
The relationship between fecal incontinence and vaginal delivery in the postmenopausal stage. ( 28913133 )
2017
10
Analysis of Factors Associated with Patient or Caregiver Regret following Surgery for Fecal Incontinence. ( 28728991 )
2017
11
Diagnostic accuracy of anorectal manometry for fecal incontinence: a meta-analysis. ( 29103343 )
2017
12
Effect of a 1-Piece Drainable Pouch on Incontinence-Associated Dermatitis in Intensive Care Unit Patients With Fecal Incontinence: A Comparison Cohort Study. ( 29117083 )
2017
13
Contemporary short- and long-term outcomes in patients with unremitting constipation and fecal incontinence treated with an antegrade continence enema. ( 27817835 )
2017
14
Prevalence of fecal incontinence in a cohort of systemic sclerosis patients within a regional referral network. ( 29163972 )
2017
15
Electrophysiological Basis of Fecal Incontinence and Its Implications for Treatment. ( 29159162 )
2017
16
Fecal incontinence in patients with spina bifida: The target is the rectum. ( 28950040 )
2017
17
What Works to Improve and Manage Fecal Incontinence in Care Home Residents Living With Dementia? A Realist Synthesis of the Evidence. ( 28859818 )
2017
18
Sacral Neuromodulation for Fecal Incontinence: A Review of the Central Mechanisms of Action. ( 28723864 )
2017
19
Effectiveness of Bulking Agent (Solesta) Therapy in Fecal Incontinence in Patients Refractory to Conventional Therapies. ( 29173359 )
2017
20
Administration of a Sol-Gel Formulation of Phenylephrine Using Low-Temperature Hollow Microneedle for Treatment of Intermittent Fecal Incontinence. ( 29181686 )
2017
21
Continuing Medical Education: September 2017: Fecal Incontinence Is Associated With Mortality Among Older Adults With Complex Needs: An Observational Cohort Study. ( 28874858 )
2017
22
Sacral Nerve Stimulation for Fecal Incontinence: How Long Should the Test Phase Be? ( 29112568 )
2017
23
Physical Therapy for Fecal Incontinence in Children with Pelvic Floor Dyssynergia. ( 28807359 )
2017
24
Validation of Risk Factors for Fecal Incontinence in Patients With Crohn's Disease. ( 28682970 )
2017
25
Temperature-Controlled Delivery of Radiofrequency Energy in Fecal Incontinence: A Randomized Sham-Controlled Clinical Trial. ( 28682972 )
2017
26
Surgical Interventions and the Use of Device-Aided Therapy for the Treatment of Fecal Incontinence and Defecatory Disorders. ( 28838787 )
2017
27
Outcomes of Gatekeeper<sup>TM</sup>prosthesis implantation for the treatment of fecal incontinence: a multicenter observational study. ( 29159781 )
2017
28
Clinical anatomy of fecal incontinence in women. ( 28699286 )
2017
29
Neurostimulation for fecal incontinence after correction of repair of imperforate anus. ( 28352637 )
2017
30
Continuing Medical Education Questions: September 2017: Fecal Incontinence Is Associated With Mortality Among Older Adults With Complex Needs: An Observational Cohort Study. ( 28874872 )
2017
31
Sacral nerve stimulation for constipation and fecal incontinence in children: Long-term outcomes, patient benefit, and parent satisfaction. ( 28799195 )
2017
32
Management of Fecal Incontinence in Older People With Dementia Resident in Care Homes: A Realist Synthesis-The FINCH Study. ( 28739491 )
2017
33
Fecal Incontinence Is Associated With Mortality Among Older Adults With Complex Needs: An Observational Cohort Study. ( 28762377 )
2017
34
Long-term Experience of Magnetic Anal Sphincter Augmentation in Patients With Fecal Incontinence. ( 27926562 )
2017
35
A Pilot Clinical Study of a Safe and Efficient Stool Management System in Patients With Fecal Incontinence. ( 29324429 )
2017
36
Post-surgical fecal incontinence. ( 29290046 )
2017
37
Examining Sensory Overresponsiveness in Preschool Children With Retentive Fecal Incontinence. ( 28809659 )
2017
38
Fecal incontinence as a moderator between dietary intake and depressive symptoms among a sample of older adults obtained from the National Health and Nutrition Examination Survey (NHANES). ( 29171958 )
2017
39
Behavioral outcomes of a novel, pelvic nerve damage rat model of fecal incontinence. ( 29144006 )
2017
40
Metabolites and microbial composition of stool of women with fecal incontinence: Study design and methods. ( 28763566 )
2017
41
Rationale for Investigating Stool Metabolites and Microbiota in Women With Fecal Incontinence. ( 28059923 )
2017
42
Novel insights into fecal incontinence in men. ( 27881404 )
2017
43
The anal canal is the fine line between "fecal incontinence and colitis" after a pull-through for Hirschsprung disease. ( 28941931 )
2017
44
Microstructural white matter brain abnormalities in patients with idiopathic fecal incontinence. ( 28730720 )
2017
45
Irritable Bowel Syndrome and Quality of Life in Women With Fecal Incontinence. ( 27918339 )
2016
46
Role of Permacol Injection in the Treatment of Patients With Fecal Incontinence. ( 27218094 )
2016
47
Normal tissue complication probability (NTCP) models for late rectal bleeding, stool frequency and fecal incontinence after radiotherapy in prostate cancer patients. ( 27157889 )
2016
48
On the prevalence of constipation and fecal incontinence, and their co-occurrence, in the Netherlands. ( 27913883 )
2016
49
Dynamic Article: Percutaneous Nerve Evaluation Versus Staged Sacral Nerve Stimulation for Fecal Incontinence. ( 27602927 )
2016
50
Incontinence-Associated Dermatitis in Nursing Homes: Prevalence, Severity, and Risk Factors in Residents With Urinary and/or Fecal Incontinence. ( 27749788 )
2016

Variations for Fecal Incontinence

Expression for Fecal Incontinence

Search GEO for disease gene expression data for Fecal Incontinence.

Pathways for Fecal Incontinence

GO Terms for Fecal Incontinence

Sources for Fecal Incontinence

3 CDC
7 CNVD
9 Cosmic
10 dbSNP
11 DGIdb
16 ExPASy
18 FMA
27 GO
28 GTR
29 HGMD
30 HMDB
31 HPO
32 ICD10
33 ICD10 via Orphanet
34 ICD9CM
35 IUPHAR
36 KEGG
37 LifeMap
39 MedGen
41 MeSH
42 MESH via Orphanet
43 MGI
45 NCI
46 NCIt
47 NDF-RT
50 NINDS
51 Novoseek
53 OMIM
54 OMIM via Orphanet
58 PubMed
60 QIAGEN
65 SNOMED-CT via HPO
66 SNOMED-CT via Orphanet
67 TGDB
68 Tocris
69 UMLS
70 UMLS via Orphanet
Content
Loading form....